On 18 November 2017
ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 18 November 2017, to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter / Half year ended September 30, 2017Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)